CY1108983T1 - Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων - Google Patents
Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσωνInfo
- Publication number
- CY1108983T1 CY1108983T1 CY20091100442T CY091100442T CY1108983T1 CY 1108983 T1 CY1108983 T1 CY 1108983T1 CY 20091100442 T CY20091100442 T CY 20091100442T CY 091100442 T CY091100442 T CY 091100442T CY 1108983 T1 CY1108983 T1 CY 1108983T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- diphomatise
- myths
- peroxide
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Αποκαλύπτεται η χρήση μιμητικών της SOD, ιδιαίτερα μιμητικών της SOD συμπλόκου πεντααζακυκλικού Μn(ΙΙ), για την αγωγή του AMD, της DR και του οιδήματος του αμφιβληστροειδούς.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34038901P | 2001-12-14 | 2001-12-14 | |
EP02786915A EP1463563B1 (en) | 2001-12-14 | 2002-12-06 | Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108983T1 true CY1108983T1 (el) | 2014-07-02 |
Family
ID=23333158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091100442T CY1108983T1 (el) | 2001-12-14 | 2009-04-14 | Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων |
Country Status (19)
Country | Link |
---|---|
US (2) | US7759333B2 (el) |
EP (1) | EP1463563B1 (el) |
JP (1) | JP2005513063A (el) |
KR (1) | KR100951606B1 (el) |
CN (2) | CN1620325A (el) |
AT (1) | ATE422944T1 (el) |
BR (1) | BR0214957A (el) |
CA (1) | CA2470721C (el) |
CY (1) | CY1108983T1 (el) |
DE (1) | DE60231246D1 (el) |
DK (1) | DK1463563T3 (el) |
ES (1) | ES2319399T3 (el) |
HK (1) | HK1069785A1 (el) |
MX (1) | MXPA04005601A (el) |
PL (1) | PL210225B1 (el) |
PT (1) | PT1463563E (el) |
SI (1) | SI1463563T1 (el) |
WO (1) | WO2003051458A1 (el) |
ZA (1) | ZA200404435B (el) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1620325A (zh) * | 2001-12-14 | 2005-05-25 | 艾尔科公司 | 治疗眼睛障碍和疾病的超氧化物歧化酶模拟物 |
US20050130951A1 (en) * | 2003-12-11 | 2005-06-16 | Alcon, Inc. | Superoxide dismutase mimics for the treatment of optic nerve and retinal damage |
US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
BRPI0918337A2 (pt) | 2008-12-19 | 2017-05-30 | Abbott Lab | composto, composição farmacêutica, método de tratamento, método para tratar uma doença ou condição causada, exacerbada ou resultante de um excesso de plaquetas ou ativação indesejada de plaquetas em um paciente, método para reduzir a contagem de plaquetas circulantes em um paciente e uso |
PT2433640T (pt) | 2010-09-24 | 2020-04-03 | Omnivision Gmbh | Composição compreendendo sod, luteína e zeaxantina |
KR101214364B1 (ko) * | 2011-02-15 | 2012-12-21 | 한림대학교 산학협력단 | 수퍼옥사이드 디스뮤테이즈 융합 단백질을 함유하는 안과 질환 예방 또는 치료용 약제학적 조성물 |
CN103906756B (zh) * | 2011-09-26 | 2020-03-03 | 加莱拉实验室有限责任公司 | 用于治疗疾病的方法 |
KR102531246B1 (ko) * | 2021-12-23 | 2023-05-11 | 주식회사 제노포커스 | 수퍼옥시드 디스뮤타제 및 이의 건성 황반변성의 예방 또는 치료용 용도 |
WO2023224136A1 (ko) * | 2022-05-16 | 2023-11-23 | 주식회사 제노포커스 | 수퍼옥시드 디스뮤타제 및 이의 당뇨망막병증 또는 포도막염의 예방 또는 치료용 용도 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5209926A (en) * | 1990-06-12 | 1993-05-11 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
US5124154A (en) * | 1990-06-12 | 1992-06-23 | Insite Vision Incorporated | Aminosteroids for ophthalmic use |
US6127356A (en) * | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
US5994339A (en) * | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
SE9402816D0 (sv) | 1994-08-24 | 1994-08-24 | Pharmacia Ab | Method and meams for drug administration |
US6214817B1 (en) * | 1997-06-20 | 2001-04-10 | Monsanto Company | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
US6180620B1 (en) * | 1997-06-20 | 2001-01-30 | G.D. Searle & Co. | Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
IL135949A0 (en) * | 1997-11-03 | 2001-05-20 | Univ Duke | Substituted porphyrins |
US6291506B1 (en) | 1998-08-04 | 2001-09-18 | Wisconsin Alumni Research Foundation | Method of reducing retinal ganglion cell degeneration |
GB9817845D0 (en) * | 1998-08-17 | 1998-10-14 | Glaxo Group Ltd | Chemical compounds |
WO2000023568A2 (en) | 1998-10-06 | 2000-04-27 | Albert Einstein College Of Medicine Of Yeshiva University | Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells |
CA2374472A1 (en) | 1999-05-27 | 2000-12-07 | Monsanto Company | Biomaterials modified with superoxide dismutase mimics |
CN1620325A (zh) | 2001-12-14 | 2005-05-25 | 艾尔科公司 | 治疗眼睛障碍和疾病的超氧化物歧化酶模拟物 |
-
2002
- 2002-12-06 CN CNA028280806A patent/CN1620325A/zh active Pending
- 2002-12-06 AT AT02786915T patent/ATE422944T1/de active
- 2002-12-06 JP JP2003552386A patent/JP2005513063A/ja active Pending
- 2002-12-06 PL PL369607A patent/PL210225B1/pl unknown
- 2002-12-06 KR KR1020047008842A patent/KR100951606B1/ko not_active IP Right Cessation
- 2002-12-06 US US10/498,721 patent/US7759333B2/en not_active Expired - Fee Related
- 2002-12-06 MX MXPA04005601A patent/MXPA04005601A/es active IP Right Grant
- 2002-12-06 BR BR0214957-5A patent/BR0214957A/pt not_active Application Discontinuation
- 2002-12-06 DE DE60231246T patent/DE60231246D1/de not_active Expired - Lifetime
- 2002-12-06 DK DK02786915T patent/DK1463563T3/da active
- 2002-12-06 EP EP02786915A patent/EP1463563B1/en not_active Expired - Lifetime
- 2002-12-06 WO PCT/US2002/039037 patent/WO2003051458A1/en active IP Right Grant
- 2002-12-06 CN CNA2006100774968A patent/CN101092432A/zh active Pending
- 2002-12-06 SI SI200230808T patent/SI1463563T1/sl unknown
- 2002-12-06 ES ES02786915T patent/ES2319399T3/es not_active Expired - Lifetime
- 2002-12-06 PT PT02786915T patent/PT1463563E/pt unknown
- 2002-12-06 CA CA2470721A patent/CA2470721C/en not_active Expired - Fee Related
-
2004
- 2004-06-04 ZA ZA200404435A patent/ZA200404435B/en unknown
-
2005
- 2005-03-17 HK HK05102326.6A patent/HK1069785A1/xx not_active IP Right Cessation
-
2009
- 2009-04-14 CY CY20091100442T patent/CY1108983T1/el unknown
-
2010
- 2010-04-23 US US12/766,332 patent/US8003635B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101092432A (zh) | 2007-12-26 |
US20100204194A1 (en) | 2010-08-12 |
US7759333B2 (en) | 2010-07-20 |
DE60231246D1 (de) | 2009-04-02 |
US8003635B2 (en) | 2011-08-23 |
PL369607A1 (en) | 2005-05-02 |
AU2002351267B2 (en) | 2007-04-05 |
MXPA04005601A (es) | 2004-12-06 |
KR20040063943A (ko) | 2004-07-14 |
KR100951606B1 (ko) | 2010-04-09 |
EP1463563B1 (en) | 2009-02-18 |
EP1463563A1 (en) | 2004-10-06 |
US20050032768A1 (en) | 2005-02-10 |
DK1463563T3 (da) | 2009-04-20 |
WO2003051458A1 (en) | 2003-06-26 |
CA2470721A1 (en) | 2003-06-26 |
ATE422944T1 (de) | 2009-03-15 |
SI1463563T1 (sl) | 2009-06-30 |
CN1620325A (zh) | 2005-05-25 |
PL210225B1 (pl) | 2011-12-30 |
CA2470721C (en) | 2011-07-12 |
ZA200404435B (en) | 2006-05-31 |
ES2319399T3 (es) | 2009-05-07 |
BR0214957A (pt) | 2004-12-14 |
AU2002351267A1 (en) | 2003-06-30 |
JP2005513063A (ja) | 2005-05-12 |
PT1463563E (pt) | 2009-03-19 |
HK1069785A1 (en) | 2005-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108983T1 (el) | Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων | |
BR0317026A (pt) | Mìmicos de superóxido dismutase para o tratamento de distúrbios e doenças oculares | |
WO2002085248A3 (en) | Prostanoids augment ocular drug penetration | |
EA200400518A1 (ru) | Способы лечения глазных неоваскулярных заболеваний | |
DE60334134D1 (de) | Ungsmethode von erhöhtem augeninnendruck und glaukom | |
ATE254461T1 (de) | Behandlung von augenschmerzen | |
ATE505201T1 (de) | Enzymbehandlung von nahrungsmitteln für zöliakie- sprue | |
EE05419B1 (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
ATE554763T1 (de) | Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation | |
ZA200500719B (en) | The use of the combination of ciclesonide and antihitamines for the treatment of allergic rhinitis. | |
CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
ATE375141T1 (de) | Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer | |
TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
BR0017163A (pt) | Derivados 5-hidróxi-indazol para tratamento do glaucoma | |
NO20044530L (no) | Fremgangsmate for behandling av kognitive forstyrrelser | |
CY1106409T1 (el) | Παραγωγα κινολινης | |
ATE487482T1 (de) | Superoxid-dismutase-mimika zur behandlungvon augenstörungen und erkrankungen | |
DE60224667D1 (de) | Perylenequinonen zur anwendung als sonosensitizer | |
DE60138385D1 (de) | Heilmittel zur behandlung von erkrankungen des sehnervs | |
PT1178819E (pt) | Glutationa-redutase para a terapia e profilaxia da sida | |
MXPA04010816A (es) | Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares. | |
BRPI0417549A (pt) | miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal | |
ATE344054T1 (de) | Behandlung von okularen neovaskularen erkrankungen | |
KR200249229Y1 (ko) | 이명 치료기 | |
DE60012163D1 (de) | Verwendung von ap-1 aktivatoren zur behandlung von glaukom und erhöhtem augenblutdruck |